LNLokien X. van Nunen

Lokien X. van Nunen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lokien X. van Nunen has a total of 210 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Construct Validity of a Novel Fiberoptic TAVR Guidewire for Invasive Pressure Measurements

    by Geert A.A. Versteeg, Maarten A.B. Westerhof, Niels A. Stens, Job Meuwese, Marleen H. van Wely, Aukelien C. Dimitriu-Leen, Robert-Jan M. van Geuns, Leen A.F.M. van Garsse, Guillaume S.C. Geuzebroek, Michel W.A. Verkroost, et al.

  • Open Access

    Prognostic value of algorithm-based invasive haemodynamic assessment of paravalvular regurgitation after transcatheter aortic valve replacement with self-expanding devices—the APPOSE registry

    by Niels A Stens, Geert A A Versteeg, Maxim J P Rooijakkers, Erwin Zegers, Ron Pisters, Jeroen Jaspers Focks, Bart W Driesen, Fransisco J Prins, Wouter Remkes, Lokien X van Nunen, et al.

    Background: Detecting and grading paravalvular regurgitation (PVR) following transcatheter aortic valve replacement (TAVR) remains challenging. Aims: We evaluated the prognostic value of algorithm-based invasively measured haemodynamic indices of PVR for all-cause mortality and heart failure (HF) rehospitalizations. Methods and Results: We included 727 patients who underwent TAVR with a self-expanding valve for severe native aortic stenosis between 2015 and 2021 at Radboudumc. Invasive left ventricular and aortic pressures were continuously measured and analysed offline using a validated algorithm for standardized computation of haemodynamic indices of PVR. The primary endpoint was an event-adjudicated composite of all-cause mortality and HF rehospitalization across 3-year follow-up. Algorithm-derived diastolic pressure–time index (DPTI) ≤58 and diastolic delta (DD) ≤32 mmHg were independently associated with the composite outcome (hazard ratio [HR] 1.64 [95% confidence interval (CI): 1.14, 2.37], HR 1.80 [95% CI: 1.21, 2.68], respectively). Following stratification for angiography-graded PVR, algorithm-derived invasive indices remained independently associated with the composite outcome in those with angiographic mild-moderate (HR DPTI ≤58 mmHg: 2.94, 95% CI: 1.68, 5.15) but not none/trace PVR (HR DPTI ≤58 mmHg: 0.91, 95% CI: 0.49, 1.69). Inferences remained consistent when considering only those with angiographic mild PVR (HR DPTI ≤58: 3.19, 95% CI: 1.62, 6.26). Conclusion: Algorithm-based invasive assessment of PVR showed independent prognostic value for the risk of all-cause mortality and HF rehospitalization across 3-year follow-up. Additionally, following stratification for angiography-graded PVR, haemodynamic indices remained independently associated with the composite outcome in those with angiographic mild PVR. Together, this highlights the potential of real-time automated assessment of invasive haemodynamics for risk stratification of patients undergoing TAVR.

  • Impact of Intravascular Imaging on Clinical Outcomes in Focal Versus Diffuse Coronary Artery Disease

    by Taito Arai, Koshiro Sakai, Kazumasa Ikeda, Takuya Mizukami, Frédéric Bouisset, Han Zhang, Mitsuaki Matsumura, Jeroen Sonck, Adriaan Wilgenhof, Hitoshi Matsuo, et al.

    BACKGROUND: Intravascular imaging (IVI) during percutaneous coronary intervention (PCI) improves outcomes. Pullback pressure gradient characterizes coronary artery disease patterns as focal or diffuse; however, the benefit of IVI across this spectrum remains incompletely understood. We aimed to evaluate clinical outcomes after PCI with or without IVI guidance in patients with focal and diffuse disease defined by pullback pressure gradient. METHODS: Prospective, multicenter, single-arm study of 811 patients (840 vessels) undergoing PCI. Pullback pressure gradient was calculated from manual fractional flow reserve pullbacks to define focal (pullback pressure gradient ≥0.62) or diffuse coronary artery disease. IVI use was at the operator’s discretion. The primary outcome was target vessel failure at 1-year follow-up. RESULTS: IVI-guided PCI was performed in 41% of patients. In the overall cohort, target vessel failure was lower with IVI guidance (adjusted hazard ratio, 0.60 [95% CI, 0.36–0.99]; P =0.044), with a lower incidence of cardiac death ( P =0.042). The results were consistent irrespective of the baseline coronary artery disease pattern ( P interaction =0.128). Among patients with focal disease, IVI-guided PCI was associated with a significantly lower incidence of target vessel failure compared with non-IVI-guided PCI (hazard ratio, 0.41 [95% CI, 0.18–0.91]; P =0.029). There was no statistical difference in target vessel failure with the use of IVI among patients with diffuse disease (hazard ratio, 0.91 [95% CI, 0.48–1.73]; P =0.771). CONCLUSIONS: In patients undergoing physiology-guided PCI, the use of IVI reduced clinical events at 1 year. These findings suggest that the benefit of IVI extends across the full spectrum of coronary artery disease.


  • Open Access

    Influence of Pullback Pressure Gradient on Residual Angina at One Year

    by Takuya Mizukami, Kazumasa Ikeda, Daniel Munhoz, Koshiro Sakai, Jeroen Sonck, Hitoshi Matsuo, Toshiro Shinke, Hirohiko Ando, Brian Ko, Simone Biscaglia, et al.

    BACKGROUND: The pullback pressure gradient (PPG) is a novel physiological metric that quantifies coronary artery disease patterns as focal or diffuse on a scale from 0 to 1. This study assessed the relationship between PPG and residual angina at 1 year. METHODS: PPG Global is a prospective, investigator-initiated, single-arm, multicenter study that enrolled patients with at least 1 lesion with a fractional flow reserve ≤0.80 intended to be treated with percutaneous coronary intervention. After the PPG calculation, physicians could revise treatment assignment to medical therapy or coronary artery bypass graft surgery instead of percutaneous coronary intervention. Focal and diffuse disease were defined based on the median PPG value of 0.62. Patient-reported outcomes were assessed using the Seattle Angina Questionnaire at baseline and 1-year follow-up. RESULTS: The study included 947 patients with PPG and the Seattle Angina Questionnaire at 1 year. The mean age was 67.6±10.2 years, 24% were female, and 29% had diabetes. At 1 year, patients with focal coronary artery disease reported less angina than those with diffuse disease (Seattle Angina Questionnaire angina frequency score, 95.3±9.9 versus 92.5±15.0; P =0.006). PPG was independently associated with improvement in angina ( P =0.017). CONCLUSIONS: In patients with flow-limiting coronary artery disease, a focal disease pattern defined by high PPG was associated with greater symptomatic relief at 1 year compared with diffuse disease (low PPG). By capturing the underlying pathophysiologic distribution of epicardial disease and its relation to post-treatment symptom relief, PPG may support a more tailored revascularization decision-making and percutaneous coronary intervention strategy.


  • Open Access

    Coronary computed tomography angiography guidance for selective invasive coronary angiography; a prospective registry study

    by Konrad A.J. van Beek, Mark Hinderks, Naomi Florie, Marcel van ’T Veer, Koen Schults, Mark Winkens, Peter Damman, Koen Teeuwen, Pim A.L. Tonino, Sjoerd Bouwmeester, et al.


  • Open Access

    Diagnostic Performance of Non‐Hyperemic Pressure Ratios Versus Fractional Flow Reserve Stratified by Coronary Artery: A Systematic Review and Meta‐Analysis of Individual Patient Data

    by Tatyana Storozhenko, Damien Collison, Nils P. Johnson, Koshiro Sakai, Takuya Mizukami, Toshiro Shinke, Hitoshi Matsuo, Daniel Munhoz, Dimitri Buytaert, Hirohiko Ando, et al.

    Background: In the assessment of coronary physiology, non‐hyperemic pressure ratios (NHPRs) provide an alternative to fractional flow reserve (FFR) without the need for hyperemic agents, reducing procedural time, side effects, and costs. However, it remains unclear whether NHPRs have similar diagnostic performance in the different coronary arteries. This study evaluates the diagnostic performance of NHPRs compared with FFR, stratified by coronary artery, in stable patients with coronary artery disease. Methods: We conducted a systematic review and individual patient‐level data meta‐analysis from prospective studies involving patients with intermediate to severe coronary stenosis who underwent physiological assessment with NHPRs and FFR. NHPRs included resting full‐cycle ratio or instantaneous wave‐free ratio (iFR). The diagnostic performance of NHPRs was calculated using a threshold of ≤0.89 for NHPRs with FFR ≤0.80 as the reference and by stratifying between the left anterior descending artery (LAD) and non‐LAD vessels. Results: A total of 2120 paired FFR and NHPRs (1257 resting full‐cycle ratio, 863 iFR) measurements were analyzed. The LAD artery was the interrogated vessel in 67% of cases, the left circumflex artery in 15%, and the right coronary artery in 17%. The mean NHPR and FFR values were 0.80±0.17 and 0.71±0.14, respectively. The overall sensitivity, specificity, and accuracy of NHPRs were 82%, 86%, and 83%. In non‐LAD vessels, NHPRs had significantly lower sensitivity and accuracy, but higher specificity compared with LAD (69% versus 87%, 76% versus 86%, and 91% versus 81%, respectively, P <0.001 for all). The optimal NHPRs cutoff for detecting significant lesions differed between LAD (≤0.88) and non‐LAD (≤0.92). Conclusions: NHPRs demonstrated lower diagnostic performance in non‐LAD vessels compared with the LAD. These results underscore the need for vessel‐specific interpretation of NHPR measurements.


  • Open Access

    Differential Effects of Intravenous Versus Intracoronary Adenosine on Non‐Culprit Lesion Assessment Following Acute Coronary Syndrome

    by Jonathan Los, Frans B. Mensink, Guus A. de Waard, Lokien X. van Nunen, Mohamed M. Reda Morsy, Peter Damman, Tim J. F. Ten Cate, Cyril Camaro, Aukelien C. Dimitriu‐Leen, Marleen H. van Wely, et al.

    Background: During acute coronary syndrome ( ACS ), the validity of initial non‐culprit fractional flow reserve ( FFR ) measurements remains controversial because of microvascular dysfunction and potential diminished adenosine response. Because the hyperemic effects of adenosine have been predominantly studied in stable patients, and high‐dose intracoronary administration may produce stronger hyperemia than intravenous delivery, we compared non‐culprit FFR between the acute and stabilized phases of ACS using both administration routes. Methods: Patients presenting with ACS underwent repeated physiological assessment of relevant non‐culprit lesions using both intracoronary adenosine boluses (≥100 μg) and intravenous adenosine (140 μg/kg/min) during index hospitalization and at 12‐week follow‐up. Results: A total of 53 patients (mean age 65.1±9.3 years, 7 [13.2%] women) were included in the current analysis. A significant interaction between the route of adenosine administration and change in FFR was found ( P =0.035). Baseline FFR was lower when measured with intracoronary adenosine (mean difference: −0.02, 95% CI , −0.03 to −0.01). Over time, FFR measured with intravenous adenosine decreased (mean change: −0.02, 95% CI, −0.04 to −0.00), while intracoronary adenosine showed stable values (mean change: −0.00, 95% CI, −0.02 to 0.01). Concurrently, more patients were initially classified as having a non‐flow‐limiting lesion with intravenous adenosine (27 [50.9%] versus 15 [28.3%], P =0.008), which was no longer evident at follow‐up ( P =0.146). No significant change in microvascular function was observed. Conclusions: During ACS , adequate intracoronary adenosine boluses elicit a stronger hyperemic response than intravenous adenosine administration, yielding lower initial FFR values that remain stable over time. Further research is warranted to investigate the dose‐dependent hyperemic effects of intravenous adenosine during the acute phase of ACS .

  • Open Access

    Impact of Pullback Pressure Gradient on Clinical Outcomes after Percutaneous Coronary Interventions

    by Kazumasa Ikeda, Takuya Mizukami, Koshiro Sakai, Frederic Bouisset, Jeroen Sonck, Adriaan Wilgenhof, Hitoshi Matsuo, Toshiro Shinke, Hirohiko Ando, Masahiro Hada, et al.

    BACKGROUND: Impaired flow following percutaneous coronary intervention (PCI) is a known predictor of adverse outcomes. The pullback pressure gradient (PPG) is a novel physiological metric that differentiates focal from diffuse disease and enables prediction of post-PCI fractional flow reserve (FFR). This post hoc analysis of the PPG Global (NCT04789317) study aimed to evaluate the prognostic performance of a PPG model for predicting post-PCI FFR and to determine whether the predicted physiological outcome is associated with adverse events following PCI. METHODS: Prospective and multicenter study including patients with hemodynamically significant coronary artery disease undergoing PCI. A prediction model based on FFR and PPG was used to estimate post-PCI FFR. Based on the predicted values, vessels were classified as having either optimal or suboptimal post-PCI physiology. The primary end point was target vessel failure at 1 year. Target vessel failure was defined as a composite of cardiac death, target-vessel myocardial infarction, and ischemia-driven target vessel revascularization. RESULTS: A total of 855 patients (890 vessels) were analyzed. The mean difference between predicted and measured post-PCI FFR was 0.001 (limits of agreement, –0.10 to 0.10). There was a strong correlation between predicted and measured delta FFR ( r =0.92 [95% CI, 0.91–0.93]; P P =0.004). Predicted suboptimal physiology was independently associated with adverse clinical outcomes. CONCLUSIONS: PPG-predicted post-PCI physiology was associated with target vessel failure at 1 year. These findings extend the role of coronary physiology beyond diagnostic assessment to include risk stratification and outcome prediction following PCI.


  • Open Access

    Sex Differences in Atherosclerotic Coronary Artery Disease Patterns

    by Kazumasa Ikeda, Daniel Munhoz, Sofie Brouwers, Jeroen Sonck, Hitoshi Matsuo, Toshiro Shinke, Hirohiko Ando, Brian Ko, Simone Biscaglia, Fernando Rivero, et al.

    Background: Sex differences in coronary artery disease (CAD) have been increasingly recognized, as women present with distinct clinical characteristics and outcomes compared with men. This study investigated the impact of sex on pathophysiological CAD patterns (focal versus diffuse) in stable patients undergoing percutaneous coronary interventions (PCI). Methods: We conducted a subanalysis of the PPG Global (Pullback Pressure Gradient Global Registry) study, a multicenter, prospective trial including 993 patients (236 [23.8%] women and 757 [76.2%] men) with hemodynamically significant CAD, defined as fractional flow reserve ≤0.80. The pullback pressure gradient metric categorized CAD patterns as focal or diffuse. Patient‐reported outcomes were collected using the 7‐item Seattle Angina Questionnaire. Optimal revascularization was defined as post‐PCI fractional flow reserve ≥0.88. Results: Women were significantly older than men, with a mean age of 69.8±10.3 years compared with 67.0±10.1 years ( P P =0.093), women reported more severe symptoms compared with men, as reflected in the Seattle Angina Questionnaire‐7 angina frequency score (mean 76.7±22.9 versus 81.5±20.3, P =0.002). Women exhibited a more focal CAD pattern (pullback pressure gradient 0.65±0.16 versus 0.61±0.16, P =0.001) and achieved higher post‐PCI fractional flow reserve values (0.88±0.07 versus 0.87±0.07, P =0.02). Women undergoing PCI had a higher rate of optimal revascularization (54% versus 44%, P =0.01). Conclusions: This study reveals clinically significant differences in CAD patterns between sexes, with women demonstrating a higher burden of angina, more focal disease distribution, and better physiological results after PCI.


  • Open Access

    Vessel‐Specific Myocardial Mass in Patients With Stable Coronary Artery Disease

    by Nikolaos Stalikas, Takuya Mizukami, Frederic Bouisset, Kazumasa Ikeda, Atomu Tajima, Daniel Munhoz, Thabo Mahendiran, Adriaan Wilgenhof, Koshiro Sakai, Bjarne Noorgard, et al.

    Background: Assessing the myocardial mass at risk is essential in evaluating patients with coronary artery disease. This study aims to establish reference values for vessel‐specific myocardial mass derived from coronary computed tomography angiography, providing a quantitative assessment of the myocardial mass subtended by each epicardial vessel. Methods: Left ventricular (LV) and vessel‐specific myocardial mass were calculated from coronary computed tomography angiography using the Voronoi method in patients with stable coronary artery disease. Myocardial mass was quantified for each epicardial coronary artery with a diameter >1.5 mm. Results: We included 948 patients with 9228 epicardial coronary artery branches. Mean age was 66±9 years. The cohort was predominantly male (77%); 66% had hypertension, and 22% had diabetes. Vessel‐specific myocardial mass was calculated for 2767 main epicardial arteries (948 left anterior descending, 948 left circumflex, and 871 right coronary artery) and 6461 side branches (1888 diagonals, 1208 septals, 1422 obtuse marginals, 247 ramus intermedius, 850 right posterior descending, and 846 posterolateral branches). Median LV mass was 141 grams (interquartile range 118–166); women had smaller LV mass than men (106 [93–123] grams versus 150 [132–173] grams, P <0.001). On average, the left anterior descending subtended 42.5% [37.9–48.1] of LV mass, the left circumflex artery 28.8% [21.9–5.7], and the right coronary artery 26.4% [20.9–31.9]. Median LV mass subtended by the first septal, first diagonal, and first obtuse marginal were 8.9% [6.4–11.1], 7.9% [4.52–2.0], and 10.2% [4.52–12.0], respectively. Conclusions: This study quantified the myocardial mass subtended by each major artery in the coronary circulation. Understanding the vessel‐specific mass at risk has significant clinical implications for personalizing revascularization strategies. Registration: This is a retrospective analysis of 5 prospectively conducted trials (P3: NCT03782688; P4: NCT05253677; PPG Global: NCT04789317; Euro‐CRAFT: NCT05805462; INSIGHTFUL‐FFR: NCT05437900). No additional registration was required.